By Jennifer Southall
Adolescent and young adult survivors of kidney cancer appeared at significantly increased risk for left ventricular ejection fraction, according to study results published in Journal of the National Comprehensive Cancer Network.
Nearly half of adolescents and young adults (AYAs) treated with sorafenib (Nexavar, Bayer) and one-third of those treated with sunitinib (Sutent, Pfizer) developed hypertension, researchers noted.
Read the full article in Healio.
Robotic surgery compared favorably with standard surgery in a review and analysis of data from 1,375 patients who underwent surgery to remove cancer from the kidney and inferior vena cava. The inferior vena cava (IVC), the body’s biggest vein, carries blood out of the kidneys back to the heart. Cancer can infiltrate this vein and advance to the liver and heart. Robotic IVC thrombectomy resulted in fewer blood transfusions and fewer complications overall in patients compared to standard, open IVC thrombectomy. The findings should compel further studies of the benefits of robotic IVC thrombectomy. Read the full study from the University of Texas Health Science Center at San Antonio in ScienceDaily.